From: Richard Kahn <
Sent: Tuesday, April 7, 2015 2:38 PM
To: jeffrey E.
Subject: Foundation Medicine and Roche Complete Strategic Transaction to Advance
Molecular Information and Precision Medicine in Oncology
http://investors.foundationmedicine.com/releasedetail.dm?ReleaselD=905240
Richard Kahn
HBRK Associates Inc.
New York, NY 10022
tel
fax
cell
1
EFTA_R1_00040342
EFTA01746557